(Q45862015)

17 December 2017

title

Use of activated prothrombin complex concentrate over multiple surgical episodes in a hemophilic child with an inhibitor (English)

1 reference

17 December 2017

prothrombin complex concentrate

main subject

hemophilia

0 references

1 reference

based on heuristic

inferred from title

author

Margaret W. Hilgartner

4

object named as

Hilgartner M

1 reference

17 December 2017

Edward Gomperts

2

object named as

Gomperts ED

1 reference

17 December 2017

author name string

Heisel MA

1

1 reference

17 December 2017

McComb JG

3

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 June 1983

1 reference

17 December 2017

The Journal of Pediatrics

published in

1 reference

17 December 2017

volume

102

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

951-954

1 reference

17 December 2017

The Treatment of Patients who have Factor-VIII Antibodies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980032-8

Plasma exchange and human factor VIII concentrate in managing haemophilia A with factor VIII inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980032-8

Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980032-8

Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980032-8

The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980032-8

Disseminated intravascular coagulation and infusion of factor-VIII-inhibitor bypassing activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980032-8

Hazards of prothrombin-complex concentrates in treatment of hemophilia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2883%2980032-8

10.1016/S0022-3476(83)80032-8

7 January 2021

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017